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ABSTRACT
Objective To determine the relation between body mass
index (BMI) and liver cirrhosis and the contribution that
BMI and alcohol consumption make to the incidence of
liver cirrhosis in middle aged women in the UK.
Design Prospective cohort study (Million Women Study).
SettingWomen recruited from 1996 to 2001 in NHS
breast screening centres and followed by record linkage
to routinely collected information on hospital admissions
and deaths.
Participants 1230662 women (mean age 56 years at
recruitment) followed for an average of 6.2 years.
Main outcomemeasures Relative risk and absolute risk of
first hospital admission with or death from liver cirrhosis
adjusted for age, recruitment region, alcohol
consumption, smoking, socioeconomic status, and
physical activity.
Results1811womenhada first hospital admissionwith or
died from liver cirrhosis during follow-up. Among women
withaBMI of 22.5or above, increasingBMIwas associated
with an increased incidence of liver cirrhosis: the adjusted
relative risk of cirrhosis increased by 28% (relative risk
1.28, 95% confidence interval 1.19 to 1.38; P<0.001) for
every 5 unit increase in BMI. Although the relative increase
in the riskof liver cirrhosis per 5unit increase inBMIdidnot
differ significantly according to the amount of alcohol
consumed, the absolute risk did. Among women who
reported drinking less than 70 g alcohol per week, the
absolute risk of liver cirrhosis per 1000 women over five
years was 0.8 (0.7 to 0.9) for those with a BMI between
22.5 and 25 and 1.0 (0.9 to 1.2) for those with a BMI of 30
or more. Among women who reported drinking 150 g
alcohol or more per week, the corresponding figures were
2.7 (2.1 to 3.4) and 5.0 (3.8 to 6.6).
Conclusions Excess body weight increases the incidence
of liver cirrhosis. In middle aged women in the UK, an
estimated 17% of incident or fatal liver cirrhosis is
attributable to excess bodyweight. This compareswith an
estimated 42% attributable to alcohol.
INTRODUCTION
Cirrhosis of the liver is a growing health problem in the
United Kingdom, and deaths from this condition are
increasing rapidly among both men and women.1
Alcohol is a well established cause of cirrhosis, and,
although increases in alcohol consumption over the
past 10 years are likely to have contributed to the
observed rise in rates, other factors may also have a
role.1 2 Evidence from prospective studies suggests
that excess body weight may result in a substantial
increase in the risk of death from liver cirrhosis.3 As
obesity is becomingmore prevalent in the UK popula-
tion, we examined, in a large prospective cohort of
middle aged women, the relation between body mass
index and the incidence of hospital admissions with
liver cirrhosis and deaths from liver cirrhosis and
whether the relation is modified by alcohol or by
other factors.
METHODS
Study population
The Million Women Study is a prospective cohort
study of 1.3 million women who were recruited
through National Health Service (NHS) breast screen-
ing centres in England and Scotland from 1996 to
2001. At recruitment, women completed a question-
naire (available at www.millionwomenstudy.org) ask-
ing about their height, weight, alcohol consumption,
and smoking, as well as sociodemographic details,
reproductive history, and medical history. They were
asked to complete re-survey questionnaires at approxi-
mately three to four yearly intervals after recruitment
into the study to, among other things, update informa-
tion provided at recruitment. Height and weight were
also measured in a randomly selected sample of 3745
women approximately eight years after recruitment.
Study participants are followed up for hospital
admissions and deaths through linkage to centrally
held computerised health records by using their NHS
number (a unique identifier) and other identifiers
including date of birth and sex. These linked records
include the NHS central registries for deaths, cancers,
and emigrations; the hospital episodes statistics in
England4; and the Scottish morbidity records in
Scotland.5 The NHS central registries hold records of
all registered deaths, including the cause of death and
the date of death. The hospital admission databases
contain a record of all NHS inpatient admissions
from April 1997 in England and January 1981 in Scot-
land. Within each hospital record, a main diagnosis
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and up to 13 additional diagnoses are coded. During
the period of follow-up for this study, both the cause of
death and diagnoses on admission to hospital were
coded by using ICD-10 (the international classification
of diseases, version 10). All study participants gave
signed consent to be included.
Data definitions
We classified women as having a hospital admission
with liver cirrhosis or death from liver cirrhosis if, dur-
ing follow-up, they had either a hospital record or a
death registration with an ICD10 code of K70, K73,
or K74. These ICD10 codes are consistent with those
used in other epidemiological studies of liver cirrhosis
in the UK.1 We calculated body mass index as a
woman’s weight in kilograms divided by her height
in metres squared. Alcohol use was reported as stan-
dard drinks consumed on average in a week—that is,
number of glasses of wine, half pints of beer/lager, or
measures of spirits.We converted this into grams, con-
sidering one standard drink to be equivalent to 10 g of
alcohol.6
Analysis
We excluded participants from analyses if they
reported having had any type of liver disease (includ-
ing viral hepatitis) before recruitment, if they had a
hospital admission record of any liver disease before
recruitment (ICD 10 codes K70-K77, B15-B19), if
they had a diagnosis of cancer (except non-melanoma-
tous skin cancer, ICD-10 code C44) before recruit-
ment, or if their body mass index at recruitment was
unknown. We used Cox regression models to analyse
data.We followedwomen from the date of recruitment
to the date of hospital admissionwith cirrhosis, the date
of death from cirrhosis, or the last date of follow-up,
whichever came first. The last date for which we had
complete hospital and death data was 31 December
2003 for women recruited in Scotland and 31 March
2005 for those recruited in England. For a small
proportion (5%) of women recruited in England before
1April 1997, we calculated person years from this date
as hospital records were not available in England
before this time.
We estimated the risk of hospital admission with cir-
rhosis or death from cirrhosis for six categories of body
mass index (<22.5, 22.5 to <25, 25 to <27.5, 27.5 to
<30, 30 to <35, and ≥35) at recruitment and also, in
those with a value greater than 22.,5 for each 5 unit
increase. To correct for misclassification that may
result from self reporting of body mass index,7 and
for changes in body mass index over time,8 we took
the mean value in each category as that measured in
the randomly selected sample of women (n=3745)
after recruitment. We used the measured mean value
in each category of body mass index in tests of trend
across the categories.
As no natural baseline exists for categories of body
mass index, we calculated floating absolute risks and
set the reference group as women with a body mass
index of between 22.5 and 25.Comparedwith conven-
tional methods, floating absolute risks do not alter the
relative risk estimates but reduce the variances attrib-
uted to them and permit tests of trend.9 10 In regression
analyses, we used attained age as the underlying time
variable and routinely stratified all analyses for region
of recruitment (10 regions) and adjusted them for alco-
hol intake in categories (none (including never or past
drinkers) and, among drinkers, consumptions of <30,
30 to <70, 70 to <150, and ≥150 g/week), socioeco-
nomic status in fifths (according to the deprivation
index, a score based on residential address that takes
into account information on employment, household
overcrowding, and home and car ownership),11 smok-
ing status and amount smoked (never, past, current 1-9
cigarettes a day, current 10-19 cigarettes a day, and
current ≥20 cigarettes a day), and strenuous physical
activity (once a week or less, more than once a week).
We also examined the effect of adjustment for addi-
tional factors (use of hormonal therapies, parity, year
Table 1 | Characteristics of study participants at recruitment and follow-up according to body mass index (BMI) category at recruitment. Values are
percentages (numbers) unless stated otherwise
Characteristics
BMI category at recruitment
<22.5
(n=237 619)
22.5 to <25
(n=331 480)
25 to <27.5
(n=266 795)
27.5 to <30
(n=173 498)
30 to <35
(n=156 733)
≥35
(n=64 537)
All women
(n=1 230 662)
Mean (SD) measured BMI* 22.2 (2.2) 25.3 (2.3) 27.8 (2.6) 30.3 (2.7) 33.1 (3.5) 37.3 (4.9) 27.6 ( 4.9)†
Mean (SD) age (years) 55.7 (4.7) 55.9 (4.7) 56.2 (4.7) 56.3 (4.7) 56.3 (4.7) 55.8 (4.6) 56.0 (4.7)
In upper third of socioeconomic status 37.5 (88 329) 37.2 (122 267) 34.4 (90 970) 31.5 (54 328) 28.1 (43 698) 23.3 (14 927) 33.9 (414 519)
Reported drinking alcohol 79.0 (186 626) 80.8 (266 323) 78.1 (206 963) 74.5 (128 290) 69.5 (107 981) 61.2 (39 101) 76.5 (935 284)
Mean (SD) alcohol intake reported by drinkers (g/week) 59.6 (56.8) 57.0 (54.9) 53.7 (54.0) 50.6 (53.4) 46.4 (51.9) 40.8 (50.1) 54.0 (54.6)
Current smokers 25.4 (57 389) 20.6 (64 758) 19.6 (49 294) 18.8 (30 599) 17.1 (25 050) 15.3 (9 190) 20.3 (236 280)
Treated for diabetes 0.84 (2 005) 1.1 (3 625) 1.7 (4 611) 2.9 (5,021) 5.0 (7 821) 9.3 (5 985) 2.4 (29 068)
Doingstrenuousphysical activitymore thanonceaweek 46.0 (105 766) 44.4 (142 579) 39.5 (102 018) 34.7 (58 056) 29.6 (44 709) 23.9 (14 829) 39.4 (467 957)
Mean (SD) person years’ follow-up 6.2 (1.2) 6.2 (1.2) 6.2 (1.2) 6.1 (1.2) 6.1 (1.2) 6.1 (1.2) 6.2 (1.2)
No of events 414 402 343 236 283 133 1811
*Calculated as kg/m2 using measured height and weight in a randomly selected sample of cohort (see methods).
†Standardised to distribution of BMI in all women based on that reported at recruitment.
Percentages do not include missing values.
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of birth). We did sensitivity analyses to examine
whether the associations between body mass index
and liver cirrhosis varied if we used only deaths from
cirrhosis as the outcome or if we censored the first two
years of follow-up.
We also examined the effect of body mass index on
the risk of subsequent hospital admission with or death
from cirrhosis in relation to other factors that have been
found to be associated with cirrhosis, including alcohol
consumption (in drinkers with categories of intake of
<70, 70 to<150, and≥150g/week), smoking (never and
current),1213 and diabetes (treated and not treated).14 In
each of these comparisons, we divided bodymass index
into three categories (22.5 to <25, 25 to <30, and ≥30)
and set the reference group as the category of women
with the lowest body mass index and either the lowest
alcohol consumption (<70 g/week), never smokers, or
women without diabetes. We used the likelihood ratio
test to test for heterogeneity between subgroups.
We used these data to estimate standardised rates for
first hospital admissionwith or death from liver cirrho-
sis in middle aged women, by both body mass index
and alcohol intake.We standardised the rates per 1000
women over five years by age, recruitment region,
socioeconomic group, smoking, and physical activity.
We also estimated the proportion of hospital admis-
sions with or deaths from liver cirrhosis in middle
aged women in the UK that could be attributed to
body mass index and to alcohol.We did this by apply-
ing the relative risks estimated here to UK population
data on body mass index and alcohol consumption in
women in their 50s and 60s.15 16 For these calculations,
we used the relative risk of liver cirrhosis for categories
of body mass index and for categories of alcohol con-
sumption (assigning the mean alcohol consumption as
that reported at re-survey three years later to each cate-
gory, as described previously).6 We adjusted relative
risks for the effect of body mass index on cirrhosis
and for alcohol on cirrhosis for age, region, socioeco-
nomic status, smoking, and physical activity, as well as
for one another.
RESULTS
After exclusions for a diagnosis of cancer before
recruitment (n=44 196), liver disease before recruit-
ment (2156), or unknown body mass index (67 943),
we included 1 230 662 women in the analyses. Over a
mean of 6.2 person years of follow-up, 1811 women
had a first cirrhosis related hospital admission or
death and 421 of these women had cirrhosis recorded
for the first time at death. The overall incidence of first
hospital admission with or death from cirrhosis in this
population was 1.2 per 1000 women over five years.
Table 1 shows the characteristics of study partici-
pants according to categories of body mass index
reported at recruitment. On the basis of the World
Health Organization’s definitions for body mass
index, 46% of women in the study were a healthy
weight or less (body mass index <25), 36% were over-
weight (25 to <30), and 18% were obese (≥30). The
mean age of women at recruitment was 56 years, and
the mean measured body mass index was 27.6. The
proportion of women in the upper socioeconomic
group decreased with increasing body mass index. Of
the women included in these analyses, 77% reported
drinking some alcohol; among the drinkers, the mean
reported alcohol consumption was 54 g/week or
approximately five and a half standard drinks a week.
The proportion ofwomen reporting drinking any alco-
hol and the amount they drank decreasedwith increas-
ing body mass index. The proportion of women who
were current smokers and the proportion who
reported doing strenuous physical activity more than
once a week also decreased with increasing body mass
index. As expected, the proportion who reported
being treated for diabetes increased with increasing
body mass index.
Figure 1 shows the relative risks for a first hospital
admission with or death from cirrhosis according to
body mass index. Routine adjustment for socioeco-
nomic status, alcohol consumption, smoking, and phy-
sical activity in addition to age and recruitment region
did not alter the pattern of risks substantially (table 2).
Compared with the reference group (women with a
body mass index of 22.5 to <25), both the women
Table 2 | Minimally adjusted and fully adjusted relative risk of cirrhosis related hospital
admission and death according to measured mean body mass index (BMI) in BMI category at
recruitment
BMI category at recruitment
(mean BMI*)
Minimally adjusted
relative risk†
Adjusted relative risk‡
(95% FCI)
<22.5 (22.2) 1.46 1.36 (1.23 to 1.50)
22.5 to <25 (25.3) (reference) 1.00 1.00 (0.91 to 1.10)
25 to <27.5 (27.8) 1.05 1.05 (0.94 to 1.17)
27.5 to <30 (30.3) 1.11 1.11 (0.97 to 1.26)
30 to <35 (33.1) 1.48 1.49 (1.33 to 1.68)
≥35 (37.3) 1.72 1.77 (1.49 to 2.10)
Per 5 unit increase in BMI§ 1.27 1.28 (1.19 to 1.38)
FCI=floated confidence interval (see methods).
*Calculated using measured height and weight in randomly selected sample of cohort (see methods).
†Adjusted for age and region.
‡Adjusted for age, region, socioeconomic status, alcohol consumption, smoking, and physical activity.
§In women with BMI≥22.5.
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Fig 1 | Relative risk of liver cirrhosis according to body mass
index. FCI=floated confidence interval. *Relative risk plotted
against mean measured body mass index (BMI) in each BMI
category (see methods)
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who had a lower body mass index and those with a
higher bodymass indexhad a significantly greater rela-
tive risk of cirrhosis. Among women with body mass
index below 22.5, we cannot exclude the possibility
that previous illness may have contributed to weight
loss, and for this reason we focused our analyses on
women with a body mass index of 22.5 or above.
Among women who had a body mass index of 22.5
or above, little evidence existed to suggest non-linear-
ity in the relation between body mass index and the
relative risk of cirrhosis related hospital admission or
death (test for non-linearity, P=0.2). Among these
women, the estimated increase in the risk of cirrhosis
was 28% (95% confidence interval 19% to 38%) for
each 5 unit increase in body mass index.
Table 3 shows results from various sensitivity ana-
lyses. When we censored the first two years of follow-
up, 1332 cirrhosis related admissions and deaths
occurred over a mean of 4.2 years of follow-up.
When we used mortality data only, 421 deaths
occurred over a mean of 6.2 years of follow-up. In
both scenarios, the relation between body mass index
and cirrhosis was similar to that in the main analysis.
When we adjusted for additional potential confoun-
ders including reproductive history, use of hormonal
therapies reported at recruitment, and year of birth
(which, together with the routine adjustment for age,
adjusts for calendar year during follow-up), the relative
risks for the effect of bodymass index on liver cirrhosis
changed by less than 5%.
We compared the effect of body mass index on the
relative risk of cirrhosis in categories of alcohol consump-
tion, smoking, and diabetes reported at recruitment in
women with body mass index 22.5 or above (table 4).
We found that the trend in the relative risk with increas-
ing body mass index did not differ significantly between
drinkers with increasingly larger consumptions of alco-
hol (<70, 70 to <150, or ≥150 g/week) or between
women who had diabetes or not (likelihood ratio tests
for heterogeneity, P=0.7 and P=0.1). The relative risk of
cirrhosis with increasing body mass index did, however,
differ according to whether women were current smo-
kers or not (test for heterogeneity, P<0.001). Current
smokers had relative risks of cirrhosis almost three
times those of never smokers, but we found little or no
trend of increasing risk with increasing bodymass index
among current smokers.
Figure 2 shows the rates of liver cirrhosis per 1000
women in this cohort over five years. The rates
increase both with body mass index and with the
amount of alcohol consumed. Although the relative
risk per unit increase in body mass index does not
vary by alcohol intake, the absolute risk does. In
women drinking less than 70 g alcohol per week
(mean intake 0.4 drinks/day), the incidence of liver cir-
rhosis was 0.8 (95% confidence interval 0.7 to 0.9) per
1000 over five years for those with body mass index
between 22.5 and 25 and increased to 1.0 (0.9 to 1.2)
per 1000 in womenwith bodymass index 30 or above,
whereas the corresponding figures forwomendrinking
150 g or more per week (mean intake 2.5 drinks per
day) were 2.7 (2.1 to 3.4) and 5.0 (3.8 to 6.6) per 1000.
Data from population based surveys in the UK
indicate that the average alcohol intake in women is
9.3 g/day and that approximately 31% do not drink
alcohol16; the average intake among drinkers is thus
13.5 g/day. The distribution of body mass index in
middle aged women in the UK is 13% with a body
Table 3 | Sensitivity analysis comparing relative risks of cirrhosis related hospital admission and death according to measured mean body mass index (BMI)
in BMI category at recruitment in main analyses, censoring first 2 years of follow-up, and using only mortality data
BMI category at recruitment
(mean BMI*)
Cases Relative risk‡ (95% FCI)
Main analysis Censoring first 2 years Mortality data only Main analysis Censoring first 2 years Mortality data only
<22.5 (22.2) 414 286 106 1.36 1.26 1.30
22.5 to <25 (25.3) (reference) 402 297 103 1.00 1.00 1.00
25 to <27.5 (27.8) 343 262 77 1.05 1.10 0.95
27.5 to <30 (30.3) 236 169 52 1.11 1.09 1.01
30 to <35 (33.1) 283 216 54 1.49 1.59 1.24
≥35 (37.3) 133 102 29 1.77 1.91 1.81
Per 5 unit increase in BMI† 1397 1046 315 1.28 1.31 1.24
FCI=floated confidence interval (see methods).
*Calculated using measured height and weight in a randomly selected sample of cohort (see methods).
†In women with BMI≥22.5.
‡Adjusted for age, region, socioeconomic status, alcohol consumption, smoking, and physical activity.
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mass index under 22.5, 21%with between 22.5 and 25,
39% overweight, and 28% obese.15 On the basis of
these figures, we estimate that in middle aged women
in the UK, approximately 42% of hospital admissions
with cirrhosis or deaths fromcirrhosis canbe attributed
to alcohol consumption and 17% to excess body
weight (body mass index ≥25).
DISCUSSION
In this study of middle aged women in the UK who
consume low to moderate amounts of alcohol, we
found that compared with women with a body mass
index between 22.5 and 25, those whowere overweight
or obese had an increased risk of liver cirrhosis; the risk
increased by about 28% for each 5 unit increase in body
mass index. The relative increase in the risk of liver cir-
rhosis was not altered by alcohol consumption; how-
ever, the absolute increase in liver cirrhosis rates with
increasing bodymass index was substantially greater in
women who reported that they drank 150 g or more of
alcohol per week (an average of two and a half drinks a
day) than in those reporting drinking less than 70 g a
week (an average of about half a drink a day).
Findings in relation to other studies
Our findings on the relation between body mass index
and liver cirrhosis are broadly consistent with those of
previous prospective studies,3 17 but the magnitude of
the risk estimate is somewhat lower than that described
in a large collaborative reanalysis of data from prospec-
tive studies,3 The collaborative reanalysis differed in
that it included men and women, used mortality from
liver cirrhosis as the end point, and excluded the first
five years of follow-up. We found that women with a
body mass index below 22.5 had a greater relative risk
of liver cirrhosis than did those with a bodymass index
between 22.5 and 25, and, similar to results from the
large collaboration,3 this increased risk remained after
exclusion of the first few years of follow-up (see table 3).
Interpreting the relevance of associations between low
bodymass index and chronic disease such as cirrhosis is
difficult, as analysesmaynot adequately compensate for
the likelihood that early liver disease may affect body
mass index before the first hospital admission or death
occurs—for example, by reducing appetite or by caus-
ing malabsorption. For this reason, we focused on
women with a body mass index of 22.5 or above.
Obesity results in an increase in fat deposition within
the hepatocytes and the development of fatty liver
(hepatic steatosis). This can lead to inflammation (non-
alcoholic steatohepatitis) and subsequent liver fibrosis
and cirrhosis,18 although the mechanisms that deter-
mine whether fibrosis and cirrhosis develop are poorly
understood.19 Fatty liver is also found in people with a
high alcohol intake anddiabetes, andhepatic steatosis in
the presence of diabetes may increase the likelihood of
progression to cirrhosis.19 We found that the relative
risks associated with increasing body mass index did
not vary with moderate alcohol intake or with a history
of diabetes but did varyby smokinghistory.The limited
literature on smoking and its association with liver cir-
rhosis makes it difficult to draw conclusions about what
factors may underlie this result.
Strengths and limitations
Owing to the large number of cases in this prospective
study, we were able to estimate reliably the association
between body mass index and incidence of liver cir-
rhosis in middle aged women. We were also able to
examine whether this association was modified by
low to moderate alcohol intake (up to about two and
a half drinks a day on average), smoking, and diabetes
in women. Only a small proportion of women in this
cohort reported consuming more than three drinks a
day, so we were unable to look at the effects of heavy
alcohol consumption. Viral hepatitis is also an impor-
tant cause of cirrhosis, but because of the low rates in
this study population of predominantly white middle
aged UK women,2 20 and the lack of serological evi-
dence to identify participants with viral hepatitis, we
could not examine whether the effect of body mass
index on cirrhosis is modified by this factor.
We used NHS hospital records and mortality
records to ascertain outcomes. Mortality records are
used in most epidemiological studies of liver
cirrhosis1 3; although the use of hospital admission
data is novel for identifying liver cirrhosis events, link-
age to hospital data has been shown to be good,5 and
hospital diagnoses are coded independently of the
study investigators. Our sensitivity analyses in which
we compared our main findings for deaths only with
those for hospital admissions and deaths (table 3) were
consistent.
Table 4 | Relative risk of cirrhosis according to body mass index (BMI) in women drinking <70, 70 to <150, and ≥150 g/week alcohol; in never and current
smokers; and in women with and without diabetes
BMI category at
recruitment
Relative risk* (95%FCI) according
to reported alcohol consumption
Relative risk* (95%FCI) according
to smoking status
Relative risk* (95%FCI) according
to diabetes status
<70 g/week 70 to <150 g/week ≥150 g/week Never Current No diabetes Diabetes
22.5 to <25 1.00 (0.85 to 1.17)
(reference)
1.59 (1.31 to 1.92) 3.44 (2.70 to 4.37) 1.00 (0.83 to 1.20)
(reference)
2.68 (2.31 to 3.13) 1.00 (0.90 to 1.11)
(reference)
4.29 (2.74 to 6.73)
25 to <30 0.96 (0.84 to 1.10) 1.83 (1.56 to 2.16) 3.82 (3.09 to 4.72) 1.23 (1.07 to 1.41) 2.47 (2.15 to 2.85) 1.05 (0.96 to 1.15) 4.37 (3.30 to 5.78)
≥30 1.35 (1.15 to 1.59) 2.31 (1.81 to 2.94) 6.53 (4.98 to 8.55) 1.66 (1.41 to 1.96) 2.96 (2.43 to 3.62) 1.38 (1.24 to 1.54) 5.94 (4.83 to 7.31)
FCI=floated confidence interval (see methods).
*Adjusted for age, region, socioeconomic status, physical activity, and alcohol consumption and smoking as appropriate.
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Body mass index and alcohol consumption are
known to be affected by reporting errors, with some
under-reporting of body mass index among more
overweight people and some under-reporting of alco-
hol consumption in heavier drinkers. With respect to
body mass index, in order to minimise misclassifica-
tion, we analysed and presented the results by using
values measured subsequently within each category
of bodymass index.With respect to alcohol consump-
tion, as the women in this study drank mostly low to
moderate quantities of alcohol, misclassification may
be less likely to affect our findings. To account for
regression dilution bias, we calculated trends across
categories of alcohol consumption reported at recruit-
ment but assigned the level of intake in each category
as the average alcohol consumption reported subse-
quently. The proportion of women in the Million
Women Study who reported drinking more than
150 g/week of alcohol is less than that estimated from
UK population surveys of women in this age range,15
and, as mentioned previously, our findings may not
apply to heavy drinkers.
Implications
Our results suggest that compared with the other
known risk factors for cirrhosis, the effect of obesity is
moderate (relative risk 1.28 per 5 unit increase for
women with body mass index ≥22.5). In the UK, mid-
dle aged women are not heavy consumers of alcohol.16
Among women in this study who reported drinking an
average of about a third to a half an alcoholic drink a
day,we estimated that over five years 0.8 in 1000with a
healthy weight will be admitted to hospital with or will
die from liver cirrhosis compared with 1.0 in 1000
women who are obese. However, among women
who reported drinking an average of two and a half
alcoholic drinks a day, over five years 2.7 in 1000
with a healthy weight will be admitted to hospital
with or will die from liver cirrhosis compared with
5.0 in 1000womenwho are obese.We cannot estimate
the effects of excess body weight on the incidence of
liver cirrhosis in heavy consumers of alcohol, or in
men; to better understand what factors underlie the
rising rates death from liver cirrhosis in the UK, the
effects of overweight and obesity in these populations
warrant further investigation.
In summary, excess body weight clearly makes an
independent contribution to rates of liver cirrhosis,
and in middle aged women we estimated this to be
about 17% of all cirrhosis related hospital admissions
and deaths, or almost half of the proportion attributa-
ble to alcohol. From a public health perspective, redu-
cing both excessive alcohol consumption and
excessive body weight should lead to a reduction in
the incidence of liver cirrhosis.
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